M. Salah Shurbaji
|
|
M. Salah Shurbaji, M.D. Professor, Medical Director, Pathology Laboratory Director, Pathology ResidencyProgram
|
Education:
BS, American University of Beirut, Beirut, Lebanon
MS, American University of Beirut, Beirut, Lebanon
MD, American University of Beirut, Beirut, Lebanon
Training:
Residency: Johns Hopkins Hospital
Postdoctoral Research Fellowship: Johns Hopkins University School of Medicine
Certification:
Anatomic and Clinical Pathology, American Board of Pathology
Cytopathology, American Board of Pathology
Clinical Focus:
Genitourinary Pathology, Surgical pathology, and Cytopathology
Research Interests:
Genitourinary diseases
Selected Publications:
Burja IT, Shurbaji MS. The clinical impact of identifying Trichomonas vaginalis on cervicovaginal (Pap) smears. Diagn Cytopathol. 24:195-199, 2001.
Shurbaji MS, Burja IT, Sawyer WL. Clinical significance of identifying Candida on cervicovaginal (Pap) smears. Diagn Cytopathol. 21:14-17, 1999.
Burja IT, Thompson SK, Sawyer WL, Shurbaji MS. Atypical glandular cells of undetermined significance (AGUS) on cervical smears: A study with cytohistologic correlation. Acta Cytol. 43:351-356, 1999.
Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression in prostate cancer. Hum Pathol 27:917-921, 1996.
Shurbaji MS, Kalbfleisch, JH, Thurmond TS. Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer. Hum Pathol, 26:106-109, 1995.